Pignot Géraldine Association Française d'Urologie - AFU GETUG Alexandre de La Taille Véronique Phé Benjamin Pradere Gaelle Fiard Nadia Abid Sabine D. Brookman-May Karim Bensalah D Borchiellini Friederike Schlürmann

GETUG-18 Positive : 80 Gy improved PFS and OS over 70 Gy with no detrimental effect on QoL in high risk patients.

Présentation au GETUG sur l’immunothérapie en urologie chez le sujet âgé !

📊📈
Gastrointestinal metastasis (GIM) of RCC
GETUG retrospective study

➡️74 patients
➡️Mostly gastric and duodenal
➡️Median time from diagnosis to GIM: 5.4 years, from first metastasis to GIM: 1.9 years
➡️19% were synchronous to non-GI metastases, 5% were GIM without non-GI…

GETUG 18: for patients with local, high risk prostate cancer who receive primary radiation and long term ADT, radiation dose matters.

80 Gy (via IMRT) is better than 70 Gy.
Improved PFS, cancer-specific survival and OS.

A few points:
- Pts received either pelvic node…

#GETUG -AFU 18 trial. Better PFS, OS for high risk, node neg PC for 80 vs 70 Gy XRT + 3yr ADT. #ASCOGU Christophe Hennequin

DIALOG /GERICO à la journée du GETUG .
Merci au comité scientifique pour cette invitation!

#GUSymposium GETUG 18 shows that dose-escalated RT to prostate to 80 Gy improves OVERALL survival. I was not expecting that!

Thank to the GETUG to offer a full session to geriatric oncology group DIALOG in their National day! ⁦Laurence Albiges⁩ ⁦GETUG⁩ ⁦SoFOG⁩ ⁦Capu B⁩ ⁦Loïc Mourey⁩ ⁦Claire Falandry⁩ ⁦rabia boulahssass⁩

Capucine on stage! Very interesting presentation on Immunotherapy in older patients ⁦Capu B⁩ ⁦GETUG⁩ ⁦Claire Falandry⁩ ⁦Mourey Loïc⁩ ⁦rabia boulahssass⁩ ⁦Laurence Albiges⁩

An editorial article looking the use of ADT with modern radiation for high risk #prostatecancer . Covering PACE-B, POP-RT, RTOG 8531, 9202, 0534, GETUG 18, and GU009 amongst others. A critical look at our data and current 'standards'. #radonc

#EAU23 .Improve local prostate treatment
cancer join us for the late breaking
news session GETUG AFU22 study Paul Sargos # study coordinator# pink area coral 2#12:30-14:00

Journée #enseignement #recherche du GETUG #Cancer - 7eme édition 👍 Alexandre de La Taille Morgan Roupret Pignot Géraldine Laurence Albiges GETUG Association Française d'Urologie - AFU Association Française d'Urologie - AFU

The OncoAlert 🚨Round Up for Day One of ASCO #GU24 in beautiful San Francisco Focused on #ProstateCancer

To REGISTER for the Newsletter go to OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

Covering:
✅CONTACT 02
✅BRCA AWAY🧬
✅FORMULA 509 ⚗️
✅GETUG 18 ☢️
✅PRESTO &…

👏 Félicitations au Pr Karim Fizazi, oncologue médical à Gustave Roussy et spécialiste de la prise en charge du cancer de la prostate et du testicule, pour sa réélection à la présidence du GETUG du Unicancer.

En savoir plus sur le #GETUG ➡ recherche.unicancer.fr/fr/les-groupes…

Cocorico! 🇫🇷
GETUG-AFU 18 : 70 Gy vs 80 Gy in HRPC with 3 years of ADT
▶️Better PFS, PCSS and OS with 80 Gy without increasing tox = level 1 evidence SOC
Hennequin Christophe GETUG ASCO 24

GETUG-P07 - OLIGOPELVIS: patterns of relapse Supiot Stéphane Piet Ost Paul Sargos GFRU

Oncologists and urologists hand in hand 🤝 (or rather wheel in wheel 🚲) for a bike race in Chicago against prostate cancer! Echoing the Mont Ventoux event. #prostate #cancer Association Française d'Urologie - AFU GETUG Alexandre de La Taille Véronique Phé Benjamin Pradere Gaelle Fiard Nadia Abid

Dr. Hennequin presented updated long term results of GETUG-18 trial in patients with high risk localized prostate cancer, comparing 2 different doses of radiotherapy (70 vs 80Gy). It is reassuring to see that 80Gy treatment showed improvement in PFS, cancer specific survival and…

Vedang Murthy Sean Collins Prostate SBRT@Georgetown University Same phase 2 randomized trial from GETUG,Association Française d'Urologie - AFU.
'' DARIUS '' TRIAL, finished in few months.

✨Efficacy end point with PSA at M6.
✨Genomic and radiomics ancillary studies will be of interest!
✨Pooled data with INTREPID also...Paul Nguyen